多臂多阶段生存试验设计,具有特定臂的停止规则
Jianrong Wu1, Yimei Li2, Liang Zhu3
1Biostatistics Shared Resource Facility, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
Journal of biopharmaceutical statistics
|September 16, 2024
概括
这项研究引入了一个新的多臂多阶段试验设计,用于存活数据. 创新的组序列设计与特定臂的停止规则提高了最佳治疗臂的选择,同时控制统计错误.
科学领域:
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
- 生存分析的分析.
背景情况:
- 传统的双臂随机试验对于评估多种治疗方法效率低下.
- 多臂多阶段 (MAMS) 设计允许同时评估,但如果过早停止,可以降低选择最佳臂的概率.
- 资源的局限性和需要测试许多干预措施的需要更高效的试验设计.
研究的目的:
- 开发一个改进的多臂多阶段 (MAMS) 生存试验设计.
- 为了提高选择最有效治疗臂的概率.
- 为了控制多个治疗臂的临床试验中的家族I型错误率.
主要方法:
- 开发一个团队顺序MAMS生存试验设计.
- 整合一个特定于手臂的停止规则,以获得早期的疗效成功.
- 统计方法来控制强烈意义上的家庭类型I错误.
主要成果:
- 拟议的设计有效地控制了家族式的I型错误.
- 该方法显著增加了选择真正最佳治疗臂的概率.
- 该设计提供了一种更有效的方法来评估多个生存干预措施.
结论:
- 新型组序列MAMS生存设计与特定臂的停止规则是一个统计学上稳健和高效的方法.
- 这种方法优化了临床试验中优质治疗方法的识别.
- 该设计为研究人员提供了一种有价值的工具,他们面临着多种实验性治疗和有限资源的挑战.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
Assumptions of Survival Analysis
110
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
110
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Censoring Survival Data
72
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
72
Actuarial Approach
68
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
68
Truncation in Survival Analysis
179
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
179


